Nana Muazin
Editorial Note: Originally published in May 2025, this resource has been updated to reflect the evolving legal landscape and the long-term systemic shifts in U.S. foreign assistance policy.
Introduction: A Fundamental Shift in Foreign Policy
In a move that has sent shockwaves through the global humanitarian community, the second term of President Donald Trump commenced with an aggressive restructuring of the United States’ role in global health. Through a series of executive actions initiated on his first day in office, the administration signaled a departure from decades of established U.S. foreign assistance policy. The strategy, centered on a philosophy of "America First" oversight and radical fiscal contraction, has led to the dissolution of the United States Agency for International Development (USAID), the freezing of critical international health funding, and the systemic reassignment of remaining responsibilities to the Department of State.
For the global public health sector, these changes represent more than mere administrative reshuffling; they constitute a fundamental disruption to the architecture of international development, particularly regarding programs focused on HIV/AIDS, maternal health, and pandemic preparedness.
Chronology of Administrative Actions
The transformation of U.S. foreign assistance did not occur in a vacuum; it was the result of a meticulously planned series of executive directives.
Phase 1: The Review and Freeze (January 2025)
On his first day in office, President Trump issued an executive order mandating a 90-day comprehensive review of all foreign aid. This was immediately followed by a "stop-work order" that effectively paralyzed the global health apparatus. By freezing all payments and services for work already in progress, the administration halted the supply chain of antiretrovirals, vaccines, and essential medical supplies in dozens of countries.
Phase 2: Dissolution of USAID (February – March 2025)
By the end of the first quarter, the administration moved to dissolve USAID as an independent entity. This process involved the immediate termination of the majority of its staff and contractors, stripping the agency of the institutional knowledge required to manage complex, multi-billion-dollar health programs.
Phase 3: Consolidation and Cancellation (April 2025 – Present)
Following the dissolution of USAID, the administration moved to cancel the vast majority of existing foreign assistance awards. While a narrow waiver process was established to allow for "life-saving humanitarian assistance," implementers have reported that these waivers are intentionally bureaucratic, difficult to obtain, and insufficient to cover the breadth of necessary medical services. The remaining skeletal remains of global health oversight have been transferred to the Department of State, a move critics argue prioritizes diplomatic expediency over clinical outcomes.
The Status of PEPFAR: A Pillar in Peril
The President’s Emergency Plan for AIDS Relief (PEPFAR) has long been considered the "gold standard" of U.S. global health intervention. Since its inception under the George W. Bush administration, it has saved millions of lives and stabilized entire regions. Under the current administration, however, PEPFAR faces an existential threat.
Current Status
The consolidation of oversight under the State Department has led to a lack of specialized technical leadership. PEPFAR operations, which previously relied on a synergy between State Department diplomacy and USAID’s technical implementation, now suffer from a "silo effect."
Field reports indicate that while the program has not been explicitly terminated in name, it has been hollowed out. Many of the local partnerships—the backbone of the program’s success—have been severed due to the cancellation of federal contracts. Without the technical oversight of USAID experts, the quality control for pharmaceutical distribution and clinical monitoring has degraded significantly.
Supporting Data: The Human and Economic Cost
The implications of these policies are supported by a growing body of data and independent reports from international NGOs and think tanks.
Disruption of Supply Chains
Independent monitoring groups have noted a 40% drop in the distribution of essential medicines in sub-Saharan Africa during the second and third quarters of 2025. The "stop-work" order created a massive bottleneck; even as some funding was released through the waiver process, the loss of logistics staff meant that vaccines expired in warehouses before reaching their intended recipients.
Clinical Outcomes
The interruption of consistent antiretroviral therapy (ART) has led to a documented rise in treatment resistance among patients in HIV-prevalent regions. Public health experts warn that the gains made over the last two decades in controlling the HIV epidemic are currently being reversed, with projections suggesting a potential surge in transmission rates over the next 24 months.
Official Responses and Legal Challenges
The administration maintains that these actions are necessary to ensure accountability and prevent the misappropriation of taxpayer funds. In a statement released by the White House press office in early 2025, officials argued that "foreign assistance must be scrutinized to ensure that it aligns strictly with the national interest and that every dollar is accounted for by the Department of State."
Conversely, the legal community has mobilized to challenge these actions. Numerous lawsuits have been filed by civil society organizations and former government officials, alleging that the executive orders violate the Impoundment Control Act and disregard congressional intent regarding foreign aid appropriations.
The Judicial Hurdle
To date, legal remedies have been limited. Courts have largely deferred to the executive branch’s broad authority over foreign policy, creating a "legal gray zone" where programs are effectively dead, despite ongoing court battles. The judiciary has proven reluctant to issue preliminary injunctions that would force the administration to resume payments, leaving aid implementers in a state of permanent uncertainty.
Implications for Global Health and U.S. Soft Power
The consequences of this policy shift extend far beyond the immediate health crises.
The Erosion of Global Health Security
The dissolution of USAID has dismantled the United States’ primary mechanism for responding to global pandemics. As the world becomes more interconnected, the absence of an agile, well-funded agency to manage global health surveillance leaves the U.S. vulnerable to emerging threats.
Diplomatic Repositioning
By scaling back humanitarian commitments, the U.S. has ceded influence in critical regions. Other global powers, particularly China, have begun to fill the void, offering "health diplomacy" packages to developing nations. This shift represents a significant decline in American soft power, as the U.S. pivots away from its role as the primary architect of global health stability.
The Future of HHS
The proposed reorganization of the Department of Health and Human Services (HHS) suggests that the administration intends to further centralize health policy. Plans to cut domestic public health funding, combined with the international cuts, indicate a move toward an isolationist health policy that prioritizes internal budget trimming over international stability.
What to Watch: The Next 12 Months
As we move into the latter half of 2025 and into 2026, stakeholders should monitor three key areas:
- Congressional Appropriation Battles: With the budget cycle approaching, members of Congress may attempt to attach riders to spending bills that mandate the reinstatement of specific health programs, setting the stage for a constitutional standoff.
- Multilateral Responses: Watch for the G7 and WHO to potentially reallocate resources to compensate for the U.S. withdrawal, which could permanently alter the funding structure of global health.
- The "Waiver" Data: As more programs attempt to navigate the complex waiver process, data will emerge on which services the administration deems "essential" versus those it intends to discard permanently.
Conclusion
The transformation of U.S. global health assistance is a profound, structural change that will define the international landscape for years to come. By dismantling the institutions that have served as the bedrock of global health for a generation, the current administration has placed the world on a precarious path. While the legal challenges continue and the political rhetoric remains polarized, the reality on the ground remains clear: the infrastructure of international aid has been fundamentally altered, and the human cost of this transition continues to mount. As the dust settles on these executive actions, the global community is left to grapple with a world where the U.S. is no longer the reliable partner in health it once was.
Reynand Wu
Sagoh
